David Callans, MD, a professor of cardiovascular medicine at the University of Pennsylvania School of Medicine, will be available to comment on the New England Journal of Medicine study on the use of automated external defibrillators (AEDs) for sudden cardiac arrests that occur in the home. Callans, author of the journal editorial that accompanies the new study, serves as associate director of electrophysiology for the Penn Health System, and has extensive experience in studying ventricular arrhythmias.
The news that the devices, which deliver shocks to restore the heart to its normal rhythm, don’t improve survival for those who have cardiac arrests at home may seem counterintuitive, he says.
“Arguments in favor of access to AEDs have an emotional quality that is not completely captured by success rates or cost efficacy of therapy,” Callans says. “But in light of the study findings and the high cost of the devices, future efforts should turn toward education, modification of risk factors and other methods for primary prevention of heart disease.”
Of the 170,000 sudden cardiac arrests that occur outside hospitals in the United States each year, about 80 percent take place in the home – with just two percent of victims surviving. The Home Automated External Defibrillator Trial (HAT), led by researchers at the Seattle Institute for Cardiac Research and the Duke University Clinical Research Institute, examined whether placement of automatic external defibrillators in the homes of patients at risk of sudden cardiac arrest would improve these survival odds.
HAT study researchers found that AEDs, which are increasingly being used in public places like airports and sports arenas, did not significantly improve a patient’s chances for survival during cardiac arrests in the home, compared with conventional resuscitation methods like CPR. Results of the study, to be presented April 1 at the American College of Cardiology Annual Scientific Session in Chicago, will be published in the April 24, 2008 print edition of the journal.
Holly Auer | EurekAlert!
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences